Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
The Oncologist|October 2, 2019
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric CancerRyan H Moy, Gustavo Dos Santos Fernandes, Philip Jonsson, et al.
Annals of Surgery|November 18, 2021
Multiinstitutional Validation Study of Cyst Fluid Protein Biomarkers in Patients With Cystic Lesions of the PancreasCaitlin A McIntyre, Clifton Rodrigues, Aadhithyaraman Vaithiya Santharaman, et al.
Cancer Discovery|November 23, 2018
<i>EGFR</i> and <i>MET</i> Amplifications Determine Response to HER2 Inhibition in <i>ERBB2</i>-Amplified Esophagogastric CancerFrancisco Sanchez-Vega, Jaclyn F Hechtman, Pau Castel, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2017
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancersJoshua D Cohen, Ammar A Javed, Christopher Thoburn, et al.
Cancer Discovery|November 11, 2017
Genetic Predictors of Response to Systemic Therapy in Esophagogastric CancerYelena Y Janjigian, Francisco Sanchez-Vega, Philip Jonsson, et al.
The New England Journal of Medicine|April 28, 2025
Nonoperative Management of Mismatch Repair-Deficient TumorsAndrea Cercek, Michael B Foote, Benoit Rousseau, et al.
Research Square|September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II TrialWungki Park, Catherine O'Connor, Joanne Chou, et al.
Nature Medicine|March 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trialWungki Park, Catherine A O'Connor, Joanne F Chou, et al.
Pageof 5